Steve Warnecke

Steve Warnecke

Steve Warnecke

Chairman and Chief Executive Officer
Evolutionary Genomics

Mr. Warnecke has served as Chairman and Chief Executive Officer of Evolutionary Genomics (symbol FNAM, engaged in agricultural biotech research and development) since 2010. Mr. Warnecke has served as Chairman of the Board of Directors and Chief Financial Officer for VetDC, Inc. since 2012, Chief Financial Officer and Board member of CereScan Corp since 2016 and Chairman of Children’s Partners Foundation (supporting Children’s Hospitals and cystic fibrosis research). He also served as Senior Vice-President of Children’s Hospital Colorado Foundation from 2003 through January 2017 and now serves on its Board of Trustees. Previously, Mr. Warnecke served as Lead Independent Director and Audit Committee Chair for Evolving Systems, Inc. (symbol EVOL, an international telecom software company), member of the Board of Directors of Bone Biologics Corp (a medical device company) and Emmaus Life Sciences (developed a drug for sickle cell disease),as Chief Financial Officer of Targeted Medical Pharma, Inc., as Chief Financial Officer and member of the Board of Directors for Bacterin International, Inc. (symbol BONE, a biologics and medical device company), member of the Board of Directors of Boppy Company, Senior Vice-President of Strategic Planning for First Data/Western Union (NYSE: FDC) and Chief Financial Officer for Frontier Airlines. Mr. Warnecke graduated from the University of Iowa with a BBA in Accounting, Finance and Management and passed the Certified Public Accountant exam in 1979